19th Conference of the International Society of Geriatric Oncology

Integrative oncology – Leaving no one behind / GENEVA Switzerland 14-16 Nov 2019


November 16, 2019 / Saturday

07:00 - 08:30

Geriatric evaluation workshop

A separate registration is required for this workshop due to limited capacity.

Chairs: Cindy Kenis (NAH), Melissa Loh (young SIOG)

1) Geriatric screening tools (VES-13, Geriatric 8), Gábor Liposits, Cindy Kenis
2) Cognitive assessments (MOCA, MMSE, Mini-Cog), Allison Magnuson, Martine Puts
3) Physical Performance Batteries (SPPB, TUG, gait speed, etc.), Mackenzi Pergolotti, Schroder Sattar
4) Chemotherapy toxicity calculators (CARG, CRASH, MAX2), Nicolò Matteo Luca Battisti, Melisa Wong
5) Life expectancy calculators, Enrique Soto Perez de Celis, Nina Rosa Neuendorff
6) Social support and psychological health, Kristen Haase, Fábio Gomes
7) Medications and polypharmacy, Erika Ramsdale, Ginah Nightingale

08:30 - 09:30

Lung cancer MDT
Chair: Ishwaria Subbiah

Case 1: stage IIIa lung cancer.
Case 2a: metastatic disease with good PS
Case 2b: metastatic disease with poor PS

Panelists: Michael T. Jaklitsch, Holly Holmes, Lore Decoster, Fabio Gomes

09:30 - 10:30

Short oral abstract presentations

Chairs: William Dale, Nina Rosa Neuendorff

O16 Functional capacity and levels of physical activity as risk factors for hospitalization in elderly cancer patients: prospective cohort, Jurema T O L Sales
O17 Functional recovery in older women undergoing surgery for gynaecological malignancies: a systematic review and narrative synthesis, Fionna E Martin
O18 Fatigue is independently associated with functional status limitations in older adults with cancer – results from the cancer and aging resilience evaluation (CARE) registry, Grant R Williams
O19 Decline in physical function (PF) is associated with pretreatment depressive symptoms, decreased mobility, more pain, and dyspnea in older cancer patients referred for systemic cancer treatment, Magnus Harneshaug
O20 Stepping on: Cancer edition changes behaviors and improves balance in older adults with cancer and their caregivers, Tanya M Wildes
O21 Risk factors for falls in older persons with cancer: a multicenter study, Jessie De Cock
O22 The high impact of preoperative social frailty on overall survival in elderly gastrointestinal cancer patients, Rei Ono
O23 Implementation of a clinical frailty pathway at a cancer centre – a quality improvement project, Fabio Gomes
O24 Geriatric and oncological predictors of survival and chemotherapy toxicities in elderly patients with metastatic non small cell lung cancer: an analysis of ESOGIA trial, Florence Canouï Poitrine
O25 Cancer-specific mortality and competing causes of death in older adults: a prospective multicenter cohort study (ELCAPA 19), Deborah Assouan
O26 Depressive symptom profiles and survival in older patients with cancer: latent class analysis of the ELCAPA cohort study, Florence Canouï Poitrine
O27 Discussing older patients during oncological multidisciplinary team meetings; is there a difference compared to younger patients? Suzanne Festen
O28 Patient-defined preferences and health outcome prioritization among older adults with cancer starting chemotherapy, Enrique Soto Perez De Celis
O29 “I have a doctor that handles all the other stuff.” Perceptions of older adults about discussing age-related conditions with their oncologists: A university of Rochester NCI community oncology research program (NCORP) geriatric assessment (GA) trial, Sindhuja Kadambi
O30 Guided geriatric interventions (GI) in older adults with cancer: What, how, and for whom? The French PACA EST Cohort Experience, Rabia Boulahssass

10:30 - 11:00  Coffee break & Poster viewing
11:00 - 12:00

Hematology MDT

Chair: Vicki Morrison

 

Case 1: AML

Case 2: Non Hodgkins Lymphoma

Panelists: Melissa Loh, Heidi Klepin, Reinhard Stauder, Konstantinos Christofyllakis, Raul Cordoba, Noam Vanderwalde

12:00 - 13:00

Keynote oral abstract presentations

Chairs: Siri Rostoft, William P. Tew

KO1 Patient Reported Outcomes Measures (PROMs) in geriatric patients undergoing major surgery for solid cancer. 90-day preliminary report on 643 patients from the Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) study, Isacco Montroni
KO2 Optimizing chemotherapy for frail and/ or elderly patients with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial, Daniel Edmund Bryan Swinson
KO3 Predicting life expectancy in older adults with advanced cancer: An evaluation of oncologists’ estimates and a geriatric assessment-based predictive model, Jennifer L Lund
KO4 Prognostic value of inflammation-based routine biomarkers in older patients with cancer: pooled analysis of three prospective cohorts, Nadia Oubaya
KO5 Cost effectiveness of a geriatric oncology clinic, Zuhair Alam

13:00- 14:30  Break for lunch
14:30 - 15:30

Prostate cancer MDT
Chair: Shane O’Hanlon

Case 1: localised prostate cancer
Case 2: metastatic prostate cancer

Panelists: Lucinda Morris, Antonella Brunello, Cecilia Lund, Patrice Jichlinski

15:30 - 16:30 Presidential session
16:30 - 17:00  Coffee break & Poster viewing
17:00 - 18:30

Debate session: Controversial issues in geriatric oncology

Chairs: Martine Extermann, Kwok-Leung Cheung, Enrique Soto Perez de Celis

Debate 1: Can chemotherapy toxicity calculators be used across diseases and settings?
Discussing arguments FOR: Allison Magnuson / AGAINST: Erin Moth

Debate 2: Breast and colorectal cancer screening in older adults.
Discussing arguments FOR: Lodovico Balducci/ AGAINST: Shabbir Alibhai